1. Home
  2. Current Affairs
  3. News Crux
  4. DCGI Approves ENTOD’s Eye Drops for Presbyopia

DCGI Approves ENTOD’s Eye Drops for Presbyopia

  • 04 Sep 2024

The Drugs Controller General of India (DCGI) has approved ENTOD Pharmaceuticals' PresVu eye drops, designed to reduce the need for reading glasses in individuals with presbyopia, a common age-related vision issue.

  • ENTOD Pharmaceuticals’ PresVu eye drops have been developed specifically to address presbyopia, a condition affecting individuals over 40 by reducing their dependency on reading glasses.
  • The approval from DCGI follows a recommendation from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
  • PresVu eye drops employ advanced dynamic buffer technology that quickly adjusts to tear pH, ensuring consistent efficacy and safety over prolonged use.
  • The eye drops also offer the additional benefit of lubricating the eyes, enhancing comfort for users who might use them regularly for years.
  • ENTOD Pharmaceuticals has applied for a patent for the formulation and process of PresVu, underscoring its innovative approach to treating presbyopia.